|
NCT04184635
|
Assessment of ECMO in Acute Myocardial Infarction With Non-reversible Cardiogenic Shock to Halt Organ Failure and Reduce Mortality (ANCHOR)
|
En recrutement
|
01 novembre 2025
|
|
NCT03846297
|
Optimisation of Decision Making for Defibrillator Implantation in Hypertrophic Cardiomyopathy
|
En recrutement
|
01 novembre 2025
|
|
NCT06215378
|
Antagonization of Heparin With Protamine Sulfate to Lower All Neurological Ischemic and Hemorrhagic Events After Transcatheter Aortic Valve Implantation for Aortic Stenosis
|
En recrutement
|
01 novembre 2025
|
|
NCT05387954
|
Transcatheter Patent Foramen Ovale (PFO) Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Between 60 and 80 Years Old : a Randomised Controlled Trial.
|
En recrutement
|
01 novembre 2025
|
|
NCT05233202
|
Levosimendan Versus Placebo Before Tricuspid Valve Surgery in Patients With Right Ventricular Dysfunction
|
En recrutement
|
01 novembre 2025
|
|
NCT05487950
|
Rivaroxaban Versus Standard of Care for Patients With Excessive Atrial Ectopy or Short Atrial Runs and High Embolism Risk
|
En recrutement
|
01 novembre 2025
|
|
NCT05784051
|
Prophylactic Frequent Premature Ventricular complexeS sUPPression on Left ventriculaR Function impairmEnt in aSymptomatic patientS
|
En recrutement
|
01 novembre 2025
|
|
NCT02793661
|
Study to Evaluate the Use of RenalGuard to Protect Patients at High Risk of AKI (STRENGTH)
|
Statut inconnu
|
20 mars 2023
|
|
NCT01385670
|
InterSEPT: In-Tunnel SeptRx European PFO Trial: A Prospective, Multi-Center Study to Evaluate the Safety and Performance of the SeptRx IPO PFO Closure System
|
Statut inconnu
|
20 mars 2023
|